Ankasa is developing ART352-L as a novel regenerative medicine. Successful development of ART352-L will enhance the osteogenic properties of patient derived stem cells used in reconstructive surgeries and provide safe and effective enhancement of bone formation in indications for which this is a significant unmet medical need.

Research

Ankasa Regenerative Therapeutics

Sanford J. Madigan

Albert Your

Stefanie Monica Gaster, Ph.D.

Gloria Matthews

The board of directors at Ankasa Regenerative Therapeutics has a history of experience in farming, medicine, and academia. The owner of Follow Your Bliss Farm, a professor at Stanford University School of Medicine, and a professor at Stanford University are all previous members of the board. Additionally, the current associate professor at UCSF was once a part of the board of directors.

Board of Directors

About

Team members

Other teams at Ankasa Regenerative Therapeutics

CEO and Executive Team

Leadership Team